Last reviewed · How we verify

NCT03943732: FA-PNEU

Trial Measuring the Clinical Impact of the FilmArray® Pneumonia Panel in Critically Ill

Completed NA Last updated 17 May 2022
What this trial tests

NA trial testing FilmArray Pneumonia in Pneumonia in 300 participants. Completed in 31 December 2020.

Timeline
27 May 2019
Primary endpoint
29 October 2020
31 December 2020

Quick facts

Lead sponsorCliniques universitaires Saint-Luc- Université Catholique de Louvain
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsequential
Maskingnone
Primary purposediagnostic
Enrollment300
Start date27 May 2019
Primary completion29 October 2020
Estimated completion31 December 2020
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain — full company profile →

Who can join

18 and older, any sex, with Pneumonia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to measure how the use of Film-Array Pneumonia (FA-PNEU) on respiratory samples of adult patients suspected of acute care pneumonia in the intensive care unit of Saint-Luc University Hospital can accelerate / improve the initiation of the optimal antibiotic treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of FilmArray Pneumonia

Trials testing the same drug.

Other recruiting trials for Pneumonia

Currently open trials in the same condition.

Other Cliniques universitaires Saint-Luc- Université Catholique de Louvain trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03943732.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing